La start-up Biobloodchipbased in the Miguel Hernández University Science Park (PCUMH) of Elche, the Award UMH Social Councilendowed with 1,000 euros, for a project that promises to revolutionize the oncological diagnosis. The initiative, led by the researcher Yolanda Giménez Molinait focuses on the creation of a In vitro diagnostic device that allows to detect metastasis early, before it becomes visible by CT or resonance.
“He project It arises from an urgent clinical need”, Explains Giménez, who, in addition, is Founder, CEO and scientific director Biobloodchip. “Once cancer is diagnosed and treated, the patient enters a monitoring phase where you can only resort to image techniques that, being radiant, cannot be applied frequently. Sometimes, when the test is repeated to the three, six or twelve months, it is already too late.” The researcher states that the objective is “to develop a device that is universal and that it can use everyone, in which the chip will directly tell us whether or not there are tumor cells and therefore We anticipate metastasis“.
Diagnosis without waiting for the image
Biobloodchip proposes an alternative: A blood analysis that allows radiological techniques to anticipatenon -invasive and more regularly. “We do not seek to replace the image, but to advance to it and offer a way of studying the patient much closer in time, which would allow us to better control the disease, ”says Giménez.
The researcher Yolanda Giménez Molina states that Biobloodchip poses an alternative to radiological tests: a blood test that allows to anticipate metastasis / INFORMATION
So far, there are methods of molecular analysis that allow to detect certain markers, but No device that does it systematically and clinical. “The challenge is not to discover how to study it, but to create a device that translates the analysis in a useful clinical result”, Argues. The objective is launch an early alert about the possible appearance of metastasis.
A multidisciplinary team with clear objectives
Currently, the project is in the base research phase. “We are developing biological and molecular bases which will then be integrated into the biomedical engineering device, ”says the promoter. These first tests will allow, in approximately one year, to obtain experimental results and request a patent.
“We are a mixed group that has shaped this idea from within the UMH Science Park”
Biobloodchip team is composed of researchers specialized in molecular, cellular and pharmaceutical biologyin addition to clinical collaborators. “We are a mixed group that has shaped this idea from within the UMH Science Park,” says Giménez. The support of the UMH has been crucial from the beginning: “The university and the park have meant a brutal impulse. They not only believe in you, but also what you can throw. ”
The Biobloodchip company, founded by Yolanda Giménez, is awarded the “Quinton” and “UMH Social Council” awards in the 14th Marathon of Creation of Start-UPS UMH / INFORMATION
Thanks to your participation in the marathon of PCUMHthe initiative was able to structure a business model, financial plan and business strategy. “With the help of the park, we land the idea and turn it into a real company”, He explains.
Essays in hospitals of the Valencian Community
The next big step is the development of a clinical studythat Biobloodchip proposes to perform in hospitals of Alicante, Elche O Elda. “We want this project to be tested first in our community, because here it is born. From there, we will expand to other hospitals in Spain, ”says the scientific director.
The researcher states that the objective is “to develop a device in which the chip will directly tell us whether or not there are tumor cells” / INFORMATION
The ultimate goal is for this biomedical product to occur and use nationallyas an example of innovation made at home. “I am tired of seeing how everything comes from outsidehow our researchers leave abroad. This device must be launched here and benefit our people first, ”says Giménez with determination. The same with which he is hopeful with the achievement of achievement:” We are sure that we are going to get it because we are a profile that has been working in research for many years, with a very prepared team. “
“I am tired of seeing how everything comes from outside, how our researchers leave abroad. This device must be launched here and benefit our people first”
Biobloodchip fully trusts its possibilities. “We have a highly qualified team and eager to work. With that binomial nothing can fail”, He says Yolanda Giménez Molina. For her, the prize received is not only an economic recognition, but also a sample of institutional support: “It drives us, gives us visibility and reminds us that science can be undertaken from university”, He concludes.
Subscribe to continue reading
